These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related]
4. Complete resolution of cutaneous larva migrans with topical ivermectin: A case report. Magri F; Chello C; Pranteda G; Pranteda G Dermatol Ther; 2019 May; 32(3):e12845. PubMed ID: 30693620 [TBL] [Abstract][Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica. East-Innis AD; Thompson DS West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894 [TBL] [Abstract][Full Text] [Related]
7. Oral ivermectin for treatment of pediculosis capitis. Ameen M; Arenas R; Villanueva-Reyes J; Ruiz-Esmenjaud J; Millar D; Domínguez-Dueñas F; Haddad-Angulo A; Rodríguez-Alvarez M Pediatr Infect Dis J; 2010 Nov; 29(11):991-3. PubMed ID: 21046698 [TBL] [Abstract][Full Text] [Related]
8. [Safety of oral ivermectin in children]. Chosidow A; Gendrel D Arch Pediatr; 2016 Feb; 23(2):204-9. PubMed ID: 26697814 [TBL] [Abstract][Full Text] [Related]
9. Long-term consequences of the misuse of ivermectin data. Alvarez-Moreno C; Cassell JA; Donkor CM; Head MG; Middleton J; Pomat W; Saka B; Yirgu R Lancet Infect Dis; 2021 Dec; 21(12):1624-1626. PubMed ID: 34672962 [No Abstract] [Full Text] [Related]
10. Ivermectin toxicosis in dogs: a retrospective study. Merola V; Khan S; Gwaltney-Brant S J Am Anim Hosp Assoc; 2009; 45(3):106-11. PubMed ID: 19411645 [TBL] [Abstract][Full Text] [Related]
11. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report. Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493 [TBL] [Abstract][Full Text] [Related]
12. Post-ivermectin encephalopathy in Senegal: a case report. Massi DG; Mansare ML; Traoré M; Ndiaye M; Diop AG; Ndiaye MM Pan Afr Med J; 2017; 27():202. PubMed ID: 28904727 [TBL] [Abstract][Full Text] [Related]
13. Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis. Nontasut P; Claesson BA; Dekumyoy P; Pakdee W; Chullawichit S Southeast Asian J Trop Med Public Health; 2005 May; 36(3):650-2. PubMed ID: 16124432 [TBL] [Abstract][Full Text] [Related]
14. Concurrent ivermectin and Solanum spp. toxicosis in a herd of horses. Norman TE; Chaffin MK; Norton PL; Coleman MC; Stoughton WB; Mays T J Vet Intern Med; 2012; 26(6):1439-42. PubMed ID: 22947027 [TBL] [Abstract][Full Text] [Related]
15. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related]
16. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)]. Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218 [TBL] [Abstract][Full Text] [Related]
17. Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis. Bomze D; Sprecher E; Geller S J Dermatol; 2022 Aug; 49(8):769-774. PubMed ID: 35475524 [TBL] [Abstract][Full Text] [Related]